Chyi‐Chia Richard Lee

16.3k total citations · 1 hit paper
114 papers, 5.4k citations indexed

About

Chyi‐Chia Richard Lee is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Chyi‐Chia Richard Lee has authored 114 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 34 papers in Immunology and 29 papers in Molecular Biology. Recurrent topics in Chyi‐Chia Richard Lee's work include Cancer-related Molecular Pathways (14 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (11 papers). Chyi‐Chia Richard Lee is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (11 papers). Chyi‐Chia Richard Lee collaborates with scholars based in United States, Japan and United Kingdom. Chyi‐Chia Richard Lee's co-authors include Steven A. Rosenberg, Nicholas P. Restifo, Michail S. Lionakis, Jean K. Lim, Philip M. Murphy, Mark Raffeld, Eric Tran, Paul F. Robbins, Richard A. Morgan and Zhiya Yu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Chyi‐Chia Richard Lee

112 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

2014 585 citations Paul F. Robbins, Sadik H. Kassim et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chyi‐Chia Richard Lee United States	40	2.0k	2.0k	1.8k	533	498	114	5.4k
Christoph Hess Switzerland	37	1.3k 0.7×	1.6k 0.8×	3.0k 1.7×	355 0.7×	633 1.3×	95	5.5k
Vito Racanelli Italy	47	1.6k 0.8×	1.7k 0.9×	2.0k 1.2×	420 0.8×	590 1.2×	151	6.5k
Stephan Segerer Germany	49	1.6k 0.8×	1.6k 0.8×	3.1k 1.8×	953 1.8×	548 1.1×	182	7.3k
Eberhard Gunsilius Austria	36	1.6k 0.8×	1.6k 0.8×	1.4k 0.8×	316 0.6×	466 0.9×	135	4.6k
Abbas Ghaderi Iran	37	1.9k 1.0×	1.3k 0.7×	2.4k 1.4×	626 1.2×	410 0.8×	358	5.5k
George Plitas United States	30	1.7k 0.9×	1.6k 0.8×	2.5k 1.4×	734 1.4×	350 0.7×	73	5.3k
Pier Luigi Tazzari Italy	49	1.4k 0.7×	3.6k 1.9×	2.2k 1.2×	979 1.8×	406 0.8×	256	8.0k
Richard J. Riese United States	36	1.1k 0.6×	1.6k 0.8×	2.2k 1.2×	381 0.7×	1.0k 2.1×	76	7.2k
Shinichiro Okamoto Japan	41	1.5k 0.7×	1.1k 0.6×	1.1k 0.6×	674 1.3×	634 1.3×	389	7.1k
Bernard Bonnotte France	42	1.6k 0.8×	1.3k 0.7×	2.8k 1.6×	352 0.7×	1.0k 2.1×	202	6.3k

Countries citing papers authored by Chyi‐Chia Richard Lee

Since Specialization

Citations

This map shows the geographic impact of Chyi‐Chia Richard Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chyi‐Chia Richard Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chyi‐Chia Richard Lee more than expected).

Fields of papers citing papers by Chyi‐Chia Richard Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chyi‐Chia Richard Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chyi‐Chia Richard Lee. The network helps show where Chyi‐Chia Richard Lee may publish in the future.

Co-authorship network of co-authors of Chyi‐Chia Richard Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chyi‐Chia Richard Lee. A scholar is included among the top collaborators of Chyi‐Chia Richard Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chyi‐Chia Richard Lee. Chyi‐Chia Richard Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Wonyong, Deborah L. Stone, Patrycja Hoffmann, et al.. (2024). Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne. Annals of the Rheumatic Diseases. 83(6). 787–798. 6 indexed citations

Ferré, Elise M. N., Vasileios Oikonomou, Chyi‐Chia Richard Lee, et al.. (2023). Case report: Discovery of a de novo FAM111B pathogenic variant in a patient with an APECED-like clinical phenotype. Frontiers in Immunology. 14. 1133387–1133387. 1 indexed citations

Lee, Chyi‐Chia Richard, et al.. (2023). Diagnosis of Mosaic Tuberous Sclerosis Complex Using Next-Generation Sequencing of Subtle or Unusual Cutaneous Findings. SHILAP Revista de lepidopterología. 3(2). 100180–100180. 3 indexed citations

Drummond, Rebecca A., Jigar V. Desai, Emily Ricotta, et al.. (2022). Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria. Cell Host & Microbe. 30(7). 1020–1033.e6. 75 indexed citations

Conlon, Kevin C., E. Lake Potter, Stefania Pittaluga, et al.. (2019). IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion. Clinical Cancer Research. 25(16). 4945–4954. 95 indexed citations

Swamydas, Muthulekha, Ji‐Liang Gao, Timothy J. Break, et al.. (2016). CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival. Science Translational Medicine. 8(322). 322ra10–322ra10. 64 indexed citations

Rothermel, Luke D., Arvind Sabesan, Daniel J. Stephens, et al.. (2015). Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. Clinical Cancer Research. 22(9). 2237–2249. 64 indexed citations

Robbins, Paul F., Sadik H. Kassim, Thai L.N. Tran, et al.. (2014). A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response. Clinical Cancer Research. 21(5). 1019–1027. 585 indexed citations breakdown →

Journy, Neige, Hubert Ducou Le Pointe, Chyi‐Chia Richard Lee, et al.. (2014). Are the studies on cancer risk from CT scans biased by indication? Elements of answer from a large-scale cohort study in France. British Journal of Cancer. 112(1). 185–193. 144 indexed citations

10.

Tran, Eric, Dhanalakshmi Chinnasamy, Zhiya Yu, et al.. (2013). Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. The Journal of Experimental Medicine. 210(6). 1125–1135. 349 indexed citations

11.

Turcotte, Simon, Alena Gros, Eric Tran, et al.. (2013). Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy. Clinical Cancer Research. 20(2). 331–343. 45 indexed citations

12.

Kornik, Rachel, Haley B. Naik, Chyi‐Chia Richard Lee, et al.. (2013). Diabetes insipidus, bone lesions, and new-onset red-brown papules in a 42-year-old man. Journal of the American Academy of Dermatology. 68(6). 1034–1038.

13.

Lai, Jin-Ping, Paul F. Robbins, Mark Raffeld, et al.. (2012). NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Modern Pathology. 25(6). 854–858. 90 indexed citations

14.

González, Amy Berrington de, Mark S. Pearce, Jane A Salotti, et al.. (2012). Development of a database of organ doses for paediatric and young adult CT scans in the United Kingdom. Radiation Protection Dosimetry. 150(4). 415–426. 54 indexed citations

15.

Fan, Tao, Shunlin Jiang, Nancy P. Y. Chung, et al.. (2011). EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/ CDKN1A Expression. Molecular Cancer Research. 9(4). 418–429. 154 indexed citations

16.

Brems, Hilde, Caroline Park, Ophélia Maertens, et al.. (2009). Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel Association. Cancer Research. 69(18). 7393–7401. 92 indexed citations

17.

Brems, Hilde, Caroline Park, Ophélia Maertens, et al.. (2009). Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association (vol 69, pg 7393, 2009). Ghent University Academic Bibliography (Ghent University). 4 indexed citations

18.

DiGiovanna, John J., Deborah Tamura, Jaime S. Brahim, et al.. (2008). Skin cancers, blindness, and anterior tongue mass in African brothers. Journal of the American Academy of Dermatology. 59(5). 881–886. 34 indexed citations

19.

Wanibuchi, Hideki, et al.. (1999). Loss of Heterozygosity in (Lewis×F344)F₁ Rat Urinary Bladder Tumors Induced with N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Followed by Dimethylarsinic Acid or Sodium L‐Ascorbate. Japanese Journal of Cancer Research. 90(8). 818–823. 5 indexed citations

20.

Am, Romanenko, Chyi‐Chia Richard Lee, Shinji Yamamoto, et al.. (1999). Urinary Bladder Lesions after the Chernobyl Accident: Immunohistochemical Assessment of p53, Proliferating Cell Nuclear Antigen, Cyclin D1 and p21^WAF1/Cip1. Japanese Journal of Cancer Research. 90(2). 144–153. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact